Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials-Reference-Cited by-同舟云学术

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials

Published:2016-05-05 Issue:18 Volume:127 Page:2189-2192
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Böll Boris¹,Goergen Helen¹,Behringer Karolin¹,Bröckelmann Paul J.¹,Hitz Felicitas²,Kerkhoff Andrea³,Greil Richard⁴,von Tresckow Bastian¹,Eichenauer Dennis A.¹,Bürkle Carolin¹,Borchmann Sven¹,Fuchs Michael¹,Diehl Volker¹,Engert Andreas¹,Borchmann Peter¹

Affiliation:

1. German Hodgkin Study Group, First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany;

2. Cantonal Hospital of St Gallen, St Gallen, Switzerland, and Swiss Group for Clinical Cancer Research, Bern, Switzerland;

3. University Hospital Münster, Münster, Germany; and

4. Third Medical Department, Paracelcus Medical University, Salzburg, Austria

Abstract

Key Points Two cycles of ABVD or AVD were equally tolerable in older early-stage favorable HL patients. Excessive toxicity including severe bleomycin-induced lung toxicity occurred in older HL patients receiving 4 cycles of ABVD.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/18/2189/1392810/2189.pdf

Reference16 articles.

1. Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009.;Sjöberg;Blood,2012

2. Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study.;Proctor;Blood,2012

3. Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.;Böll;Blood,2011

4. Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).;Halbsguth;Blood,2010

5. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin’s disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).;Ballova;Ann Oncol,2005

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients;Leukemia & Lymphoma;2024-09-13

2. Treatment approaches for older Hodgkin lymphoma patients;Current Opinion in Oncology;2024-06-20

3. Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease;American Society of Clinical Oncology Educational Book;2024-06

4. Aging Kairos: treating older Hodgkin patients;Blood;2024-03-14

5. Лечение пациентов с локальными стадиями впервые диагностированной классической лимфомы Ходжкина: обзор литературы, современные подходы и собственные данные;Clinical Oncohematology;2024-02-20